Author | Maude L. Campbell


Cardiometabolic disorders: The pharmacist's role

September 04, 2009

The term "cardiometabolic disorders" (CMD) refers to a cluster of interrelated risk factors (hypertension, elevated fasting glucose, reduced high-density lipoprotein, elevated triglycerides, and abdominal obesity) that promote the development of atherosclerotic cardiovascular disease and type 2 diabetes. With an estimated 47 million Americans facing increased risk of heart disease because of these conditions, management of patients' CMD is a priority for pharmacists.

Oral oncology drugs

February 01, 2009

The management of oral oncology drugs is an unending series of responsibilities involving safety issues, billing requirements, patient needs, prescriber details, and reimbursement challenges.